Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 17 - Issue 2 - February, 2005

News

Teaching Collection
*Saving Time, Saving Money: A Time and Motion Study with Contrast Management Systems
08/01/2008
Craig Lehmann, PhD, CC (NRCC), FACB and Mary Hotaling, MS
Craig Lehmann, PhD, CC (NRCC), FACB a...
In 1929, in an attempt to find a safe way to inject drugs for cardiac resuscitation, a young surgical resident named Werner Forssmann inserted a catheter in his antecubital vein, positioning the catheter into the right atrium of the heart. He...
In 1929, in an attempt to find a safe way to inject drugs for cardiac resuscitation, a young surgical resident named Werner Forssmann inserted a catheter in his antecubital vein, positioning the catheter into the right atrium of the heart. He...
In 1929, in an attempt to find a...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Letters to the Editor
08/01/2008
In response to: W.C. Kang, et al, Vol. 16, No. 12, pp. 725–726 Successful Management of a Resistant, Focal Calcified Lesion Following Direct Coronary Stenting with a Cutting Balloon I would like to commend Kang, et al for their innovative...
In response to: W.C. Kang, et al, Vol. 16, No. 12, pp. 725–726 Successful Management of a Resistant, Focal Calcified Lesion Following Direct Coronary Stenting with a Cutting Balloon I would like to commend Kang, et al for their innovative...
In response to: W.C. Kang, et...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Feb-05
08/01/2008
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports and reports with brief reviews, as well as articles from our special sections Interventional Pediatric Cardiology,...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports and reports with brief reviews, as well as articles from our special sections Interventional Pediatric Cardiology,...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

Feature

Case Report
Symbiot‚Ñ¢ Stent Delivery Via 8 Fr Guiding Catheter from the Right Radial Artery in an Acute Coronary Syndrome Due to a Degenerati
08/01/2008
Matthew Banks, MD, Mark Patterson, MD, Ferdinand Kiemeneij, MD
Matthew Banks, MD, Mark Patterson, M...
Recent studies have demonstrated that in the setting of acute coronary syndrome (ACS), with either intractable symptoms, acute left ventricular failure, acute mitral regurgitation, cardiac enzyme rise or electrocardiogram (ECG) change,...
Recent studies have demonstrated that in the setting of acute coronary syndrome (ACS), with either intractable symptoms, acute left ventricular failure, acute mitral regurgitation, cardiac enzyme rise or electrocardiogram (ECG) change,...
Recent studies have demonstrated...
08/01/2008
Journal of Invasive Cardiology
Case Report
Intra-operative Stenting of a Prosthetic Left Pulmonary Artery Stenosis Under Fluoroscopy
08/01/2008
Federico Brunelli, MD, Andrea Amaducci, MD, Gian Battista Danzi, MD
Federico Brunelli, MD, Andrea Amaducc...
Intraoperative stent placement under direct vision as a means of relieving pulmonary artery stenosis is an attractive alternative to complex surgical reconstruction or a valid option in patients with a limited vascular access.1,2 We describe...
Intraoperative stent placement under direct vision as a means of relieving pulmonary artery stenosis is an attractive alternative to complex surgical reconstruction or a valid option in patients with a limited vascular access.1,2 We describe...
Intraoperative stent placement...
08/01/2008
Journal of Invasive Cardiology
Case Report
Reversible Severe Ischemic Mitral Regurgitation and Cardiogenic Shock as a Complication of Percutaneous Coronary Intervention
08/01/2008
Mohammad-Reza Movahed, MD, Harry Balian, MD, Pardise Moraghebi, MD
Mohammad-Reza Movahed, MD, Harry Bali...
Coronary artery occlusion during percutaneous coronary intervention (PCI) causes regional myocardial ischemia. There are few reports or experimental studies about new onset of transient acute mitral regurgitation (MR) during PCI. However,...
Coronary artery occlusion during percutaneous coronary intervention (PCI) causes regional myocardial ischemia. There are few reports or experimental studies about new onset of transient acute mitral regurgitation (MR) during PCI. However,...
Coronary artery occlusion during...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Novel Technique for Coronary Bifurcation Lesions: Cutting Balloons, Drug-Eluting Stents and the Kissing Technique
08/01/2008
Christopher B. Wong, MD, FACC and Scott Hardin RT(R), CV
Christopher B. Wong, MD, FACC and Sco...
Bifurcation coronary lesions remain challenging for interventional cardiologists. Before coronary stents were widely used, the rate of success of percutaneous revascularization was low and the procedure was fraught with complications and...
Bifurcation coronary lesions remain challenging for interventional cardiologists. Before coronary stents were widely used, the rate of success of percutaneous revascularization was low and the procedure was fraught with complications and...
Bifurcation coronary lesions...
08/01/2008
Journal of Invasive Cardiology
Case Report
Use of Everolimus-eluting Stent with a Bioresorbable Polymer Coating for Treatment of Recurrent In-stent Restenosis
08/01/2008
Hidehiko Honda, MD, Taiichiro Meguro, MD, Kaname Takizawa, MD, Shogen Isoyama, MD
Hidehiko Honda, MD, Taiichiro Meguro,...
In-stent restenosis (ISR) often limits the long-term success of percutaneous coronary intervention. A number of clinical trials have shown that drug-eluting stents are both safe and effective in preventing ISR in de novo lesions.1,2,3 The use...
In-stent restenosis (ISR) often limits the long-term success of percutaneous coronary intervention. A number of clinical trials have shown that drug-eluting stents are both safe and effective in preventing ISR in de novo lesions.1,2,3 The use...
In-stent restenosis (ISR) often...
08/01/2008
Journal of Invasive Cardiology
Case Report
Rotational Ablation of an Unexpandable Sirolimus-Eluting Stent
08/01/2008
Stavros Hadjimiltiades, MD, *Dimitrios Tsikaderis, MD, George Louridas, MD
Stavros Hadjimiltiades, MD, *Dimitri...
The use of rotational atherectomy to ablate part of a metallic stent has been very limited, mainly because there are a small number of candidates for this type of procedure,1–7 but probably also because of the concern regarding the size and...
The use of rotational atherectomy to ablate part of a metallic stent has been very limited, mainly because there are a small number of candidates for this type of procedure,1–7 but probably also because of the concern regarding the size and...
The use of rotational...
08/01/2008
Journal of Invasive Cardiology
Percutaneous Closure of a Post-traumatic Muscular Ventricular Septal Defect Using the Amplatzer Duct Occluder
08/01/2008
Stephanie Schwalm, MD, Ziyad Hijazi, MD, Lissa Sugeng, MD, Roberto Lang, MD
Stephanie Schwalm, MD, Ziyad Hijazi,...
Post-traumatic ventricular septal defect (VSD) after penetrating cardiac trauma is infrequent, with an estimated incidence of 1–4.5% of cases.1,3 The decision to close a traumatic VSD is similar to that of a non-traumatic VSD and is based on...
Post-traumatic ventricular septal defect (VSD) after penetrating cardiac trauma is infrequent, with an estimated incidence of 1–4.5% of cases.1,3 The decision to close a traumatic VSD is similar to that of a non-traumatic VSD and is based on...
Post-traumatic ventricular...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

February 2005 Volume 17 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement